Hideyuki Haruyama
- Molecular Biology
- Organic Chemistry top 5%
- Pharmacology top 5%
- Biotechnology top 5%
- Pharmacology top 5%
- Co-authors
- Kurt WuethrichTakeshi KinoshitaShuji TakahashiMasao ShiozakiYasuteru IijimaMutsuo NakajimaTomoko TakayamaMichio Kondo
- Topics
- Microbial Natural Products and Biosynthesis (11 papers)Carbohydrate Chemistry and Synthesis (8 papers)Natural product bioactivities and synthesis (5 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
Hideyuki Haruyama
54 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 104
- Molecular Biology 586
- Organic Chemistry 407
- Pharmacology 340
- Biotechnology 191
- Pharmacology 120
Countries citing papers authored by Hideyuki Haruyama
This map shows the geographic impact of Hideyuki Haruyama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Haruyama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Haruyama more than expected).
Fields of papers citing papers by Hideyuki Haruyama
This network shows the impact of papers produced by Hideyuki Haruyama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Haruyama. The network helps show where Hideyuki Haruyama may publish in the future.
Co-authorship network of co-authors of Hideyuki Haruyama
This figure shows the co-authorship network connecting the top 25 collaborators of Hideyuki Haruyama. A scholar is included among the top collaborators of Hideyuki Haruyama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideyuki Haruyama. Hideyuki Haruyama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | Visualization of the Kernel Hierarchical Clustering Using Discriminant Analysis | 3 |
| 3 | 63 | |
| 4 | 1 | |
| 5 | 5 | |
| 6 | 13 | |
| 7 | 13 | |
| 8 | 1 | |
| 9 | 32 | |
| 10 | 21 | |
| 11 | Hydantocidin and cornexistin: new herbicidal antibiotics. | 6 |
| 12 | 15 | |
| 13 | 10 | |
| 14 | 109 | |
| 15 | 22 | |
| 16 | 32 | |
| 17 | 16 | |
| 18 | 24 | |
| 19 | 101 | |
| 20 | 4 |
About Hideyuki Haruyama
Hideyuki Haruyama is a scholar working on Pharmacology, Biotechnology and Pharmacology, having authored 58 papers that have together received 1.2k indexed citations. Recurring topics across this work include Microbial Natural Products and Biosynthesis (11 papers), Carbohydrate Chemistry and Synthesis (8 papers) and Natural product bioactivities and synthesis (5 papers). The work is most often cited by research in Biotechnology (191 citations), Pharmacology (340 citations) and Organic Chemistry (407 citations). Hideyuki Haruyama has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Kurt Wuethrich, Takeshi Kinoshita, Shuji Takahashi, Masao Shiozaki, Yasuteru Iijima, Mutsuo Nakajima, Tomoko Takayama, Michio Kondo, Tadashi Hata and TAKESHI KAGASAKI. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and FEBS Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.